Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Some people might also experience increased anxiety or jitteriness, especially in the early stages of treatment
Let's break them down
BPC-157 was placed in Category 2 ("may present significant safety risks") in 2023, removed from that category in April 2026, and is now set for a Pharmacy Compounding Advisory Committee review in late July 2026, while CJC-1295 and Ipamorelin were placed in Category 2 back in October 2023
PSPeptides supplies research-grade GHK-Cu in injectable lyophilized form, oral tablet form, and within the GLOW and KLOW blends at 99%+ verified purity with batch-specific third-party HPLC testing and US-based manufacturing
US$ 27.17
US$ 29.39
US$ 29.92
US$ 25.90
US$ 24.73
US$ 20.09
